Civic AI
Procurement intelligence
Federal contract award
EXERCISE OPTION PERIOD 4 AND MODIFY THE NUMBER OF DOSES. CHANGE THE PERIOD OF PERFORMANCE TO MARCH 4, 2026 THROUGH SEPTEMBER 29, 2032. THE TOTAL CONTRACT FUNDED VALUE INCREASED FROM $713,890,168.42 BY $59,988,838.10 TO $773,879,006.52.
AMGEN USA INC · Department of Health and Human Services
- Value
- $773,879,007
- Start
- Sep 30, 2022
- End
- Sep 29, 2032
- Action date
- Mar 6, 2026
- PIID
- 75A50122C00065
- Status
- active
- NAICS
- 541714 · RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
- Place of performance
- NEWBURY PARK, CA
- Award type
- DEFINITIVE CONTRACT
Description
EXERCISE OPTION PERIOD 4 AND MODIFY THE NUMBER OF DOSES. CHANGE THE PERIOD OF PERFORMANCE TO MARCH 4, 2026 THROUGH SEPTEMBER 29, 2032. THE TOTAL CONTRACT FUNDED VALUE INCREASED FROM $713,890,168.42 BY $59,988,838.10 TO $773,879,006.52.
Need modifications, related awards, and vendor peers? Open the full award workspace.